Targeting the endothelin receptor in prostate cancer bone metastasis: Back to the mouse?
Roh
Meejeon
M
Department of Pathology, Vanderbilt University Medical Center, Nashville, TN, USA.
Abdulkadir
Sarki A
SA
D000818:Animals; D000077868:Atrasentan; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D004195:Disease Models, Animal; D065128:Endothelin Receptor Antagonists; D006801:Humans; D008297:Male; D051379:Mice; D058990:Molecular Targeted Therapy / Q000379:methods; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D011759:Pyrrolidines / Q000494:pharmacology*
D065128:Endothelin Receptor Antagonists; D011759:Pyrrolidines; D000077868:Atrasentan